Evoglip- M Forte

Composition: Sitagliptin 50 mg + Metformin 1000 mg

Evoglip M Forte combines Sitagliptin 50 mg with a higher Metformin dose of 1000 mg, designed for patients needing stronger glycemic control. This combination targets high blood sugar through complementary mechanisms, effectively managing both fasting and post-meal glucose levels. Evoglip M Forte is a preferred option for patients with uncontrolled diabetes on lower Metformin doses.

Uses:

• Management of Type 2 Diabetes Mellitus

• Effective HbA1c lowering

• Improves insulin response

• Suitable for long-term diabetes control

Side Effects:

• Stomach upset, nausea, diarrhea

• Headache

• Cold-like symptoms

• Rare: lactic acidosis or pancreatitis

Other Details:

• Must be taken with meals

• Not suitable for patients with kidney or severe GI issues

• Helps maintain weight balance